CDK2 and leukemia: Moreover, HHT enhances the binding affinity between CDK2 and tripartite motif 21 (Trim21) by specifically targeting the interaction between CDK2 and Cyclin A. This leads to the autophagic degradation of CDK2, thereby modulating the cell cycle of leukemia cells.